Skip to main content
 
 

Building bridges in healthcare development


2 Bridge is the go-to company for those venturing into life sciences, including investors, startups, biotechs, and pharma.
The science of Healthcare Product Development is our core area of expertise and building companies according to a client-tailored design is our second nature.

10
years in business with a proven track record
25
in-house experts covering different therapeutic domains
440
projects successfully completed in the past 10 years
175
happy clients we supported in the past 10 years
12
companies we helped to build with Tiger Teams in the past 7 years

About Us

Bring science to life

At 2 Bridge, we firmly believe that the strength of a strong, trusted, cross-functional team that works in a synergistic ‘Tiger Team’ manner, is of great value for those venturing into life sciences, including investors, startups, biotechs, and pharma.

Read more ...

Our Solutions

Tiger Team tailored to your needs

We take care of our clients’ projects as if they are our own by carefully assembling the 2 Bridge Tiger Team, a team of R&D experts and healthcare executives from various domains that provides knowledge, experience, and hands-on support.
Read more ...

2 Bridge Ecosystem

The ecosystem to build your life science company

At 2 Bridge, we believe in the power of collaboration. Over the years this led to the creation of the 2 Bridge Ecosystem which is continuously growing and evolving. It consists of loyal partners, medical and other experts, Key Opinion Leaders for many indications, independent advisors, …

Read more ...

Resource Center

Together Everyone Achieves More

Become part of our ecosystem and stay informed on our latest announcements. Check out all the events we attend and organize, or just get ready to be inspired.

Read more ...

Latest Updates

Recent Posts / View All Posts

Client Testimonial – Biotech

| Quote | No Comments
A clinical stage biotechnology company focused on the treatment of immune dysregulation There is not enough room in this survey to describe the expertise, experience, professionalism, organization, collegiality, and the…

Client Testimonial – Kynexis & Forbion

| Quote | No Comments
Kynexis raised €57 Million Series A Financing to advance its lead therapeutic candidate, KYN-5356, a potential first-in-class KAT-II inhibitor for the treatment of cognitive impairment associated with schizophrenia (CIAS), toward…

Client Testimonial – AbolerIS Pharma

| Quote | No Comments
€27 Million in Series A Financing to advance its novel treatment paradigm for autoimmune and inflammatory diseases Carole holds a PhD in Immunology from University of Paris VII. Currently, Carole…